Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of Sal-like protein 4 in Epstein-Barr virus infection
FY 2021-22
Summary
Epstein-Barr virus (EBV) is a common human herpesvirus that spreads mainly through saliva, often leading to mononucleosis upon initial infection before setting up a lifetime infection. Lifetime infections involve alternation between latent and lytic modes of infection and can lead to several types of cancer. Recently our lab found that the cellular Sal-like protein 4 (SALL4) was highly expressed during the lytic cycle of EBV infection, and it was also found to be highly modified by Small Ubiquitin-like Modifier (SUMO) proteins. Adding SUMO to certain proteins can change their function in cells, including the proteins they bind and the processes they regulate. My goal is to determine why SUMO-modified SALL4 is important for EBV lytic infection and whether it has a role in the antiviral response. I will examine how SALL4 levels are affected in EBV infection of multiple cell types including B cell lymphomas, gastric carcinoma, and nasopharyngeal carcinoma, all of which can be induced by EBV infection. I will also determine the cellular and viral proteins that interact with SALL4 in the context of EBV infection in order to identify the cellular pathways that SALL4 is controlling and the EBV proteins that might target SALL4 to interfere with its functions. These studies will also be performed with SALL4 mutants that cannot be SUMO-modified in order to determine how this modification affects the functions of SALL4. Finally, I will knock out SALL4 in EBV-infected cells and determine how this affects EBV infection. Together these experiments will help us to understand the role of SALL4 in EBV infection and whether it is part of a novel antiviral response.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
467146
Name
Taylor Victoria C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of Sal-like protein 4 in Epstein-Barr virus infection
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Affinity Purification-Mass Spectrometry; Epstein-Barr Virus; Gastric Carcinoma; Lytic Infection; Nasopharyngeal Carcinoma; Proteomics; Rt-Qpcr; Sall4; Sumoylation; Western Blot
Abstract
Epstein-Barr virus (EBV) is a common human herpesvirus that spreads mainly through saliva, often leading to mononucleosis upon initial infection before setting up a lifetime infection. Lifetime infections involve alternation between latent and lytic modes of infection and can lead to several types of cancer. Recently our lab found that the cellular Sal-like protein 4 (SALL4) was highly expressed during the lytic cycle of EBV infection, and it was also found to be highly modified by Small Ubiquitin-like Modifier (SUMO) proteins. Adding SUMO to certain proteins can change their function in cells, including the proteins they bind and the processes they regulate. My goal is to determine why SUMO-modified SALL4 is important for EBV lytic infection and whether it has a role in the antiviral response. I will examine how SALL4 levels are affected in EBV infection of multiple cell types including B cell lymphomas, gastric carcinoma, and nasopharyngeal carcinoma, all of which can be induced by EBV infection. I will also determine the cellular and viral proteins that interact with SALL4 in the context of EBV infection in order to identify the cellular pathways that SALL4 is controlling and the EBV proteins that might target SALL4 to interfere with its functions. These studies will also be performed with SALL4 mutants that cannot be SUMO-modified in order to determine how this modification affects the functions of SALL4. Finally, I will knock out SALL4 in EBV-infected cells and determine how this affects EBV infection. Together these experiments will help us to understand the role of SALL4 in EBV infection and whether it is part of a novel antiviral response.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Taylor, Victoria C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~